40155-42-8

Basic information

• Product Name: 5-METHOXYPYRAZINE-2-CARBOXYLIC ACID
• Synonyms: 5-METHOXYPYRAZINE-2-CARBOXYLIC ACID;2-Carboxy-5-methoxypyrazine, 2-Carboxy-5-methoxy-1,4-diazine;5-Methoxy-pyrazinecarboxylic acid;2-Pyrazinecarboxylicacid, 5-Methoxy-;5-Methoxypyrazine-2-carboxylic;Pyrazinecarboxylic acid, 5-methoxy-
• CAS NO: 40155-42-8
• Molecular Formula: C₆H₆N₂O₃
• Molecular Weight: 154.12
• Mol File: 40155-42-8.mol

Chemical Properties

• Melting Point: 197.5-199.5℃
• Boiling Point: 296.8 °C at 760 mmHg
• Flash Point: 133.3 °C
• Appearance: /Solid
• Density: 1.371 g/cm3
• Storage Temp.: 2-8°C
• PKA: 3.18±0.10(Predicted)
• CAS DataBase Reference: 5-METHOXYPYRAZINE-2-CARBOXYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 5-METHOXYPYRAZINE-2-CARBOXYLIC ACID(40155-42-8)
• EPA Substance Registry System: 5-METHOXYPYRAZINE-2-CARBOXYLIC ACID(40155-42-8)

Safety Data

• Hazardous Substances Data: 40155-42-8(Hazardous Substances Data)

Usage

Uses

Used in Flavor and Fragrance Industry:
5-METHOXYPYRAZINE-2-CARBOXYLIC ACID is used as a flavor or fragrance ingredient for its characteristic earthy, nutty, and green aroma, enhancing the sensory experience of various products.
Used in Pharmaceutical Industry:
5-METHOXYPYRAZINE-2-CARBOXYLIC ACID is used as a building block or intermediate in the production of pharmaceuticals, contributing to the development of new drugs and therapies.
Used in Agrochemical Industry:
5-METHOXYPYRAZINE-2-CARBOXYLIC ACID is used in the formulation of agrochemicals, potentially enhancing crop protection and yield.
Used in Medicinal Research:
5-METHOXYPYRAZINE-2-CARBOXYLIC ACID is used as a subject of study in medicinal research for its potential antioxidant and anti-inflammatory properties, indicating its possible use in the development of treatments for various diseases and conditions.

Upstream product

• 36070-80-1 5-chloropyrazinoic acid 
• 67-56-1 methanol 
• 143250-10-6 2-bromo-5-methoxypyrazine 
• 201230-82-2 carbon monoxide 
• 124-41-4 sodium methylate 
• 34604-60-9 5-hydroxypyrazinoic acid 

Downstream Products

• 1200493-48-6 C₂₁H₂₅N₅O₂S 
• 1221447-97-7 C₂₈H₃₆N₆O₇ 
• 1391001-95-8 tert-butyl ((4aS,5S,7aS)-7a-(2-fluoro-5-(5-methoxypyrazine-2-carboxamido)phenyl)-5-(fluoromethyl)-4a,5,7,7a-tetrahydro-4H-furo[3,4-d][1,3]thiazin-2-yl)carbamate 
• 1391001-77-6 N-(3-((4aS,5S,7aS)-2-amino-5-(fluoromethyl)-4a,5,7,7a-tetrahydro-4H-furo[3,4-d][1,3]thiazin-7a-yl)-4-fluorophenyl)-5-methoxypyrazine-2-carboxamide 
• 1388651-33-9 N-(3-((4aS,5S,7aS)-2-amino-5-(fluoromethyl)-4a,5,7,7a-tetrahydro-4H-furo[3,4-d][1,3]thiazin-7a-yl)-4,5-difluorophenyl)-5-methoxypyrazine-2-carboxamide 
• 1391001-86-7 tert-butyl ((4aS,5S,7aS)-7a-(2,3-difluoro-5-(5-methoxypyrazine-2-carboxamido)phenyl)-5-(difluoromethyl)-4a,5,7,7a-tetrahydro-4H-furo[3,4-d][1,3]thiazin-2-yl)carbamate 
• 1391001-76-5 N-(3-((4aS,5S,7aS)-2-amino-5-(difluoromethyl)-4a,5,7,7a-tetrahydro-4H-furo[3,4-d][1,3]thiazin-7a-yl)-4,5-difluorophenyl)-5-methoxypyrazine-2-carboxamide 
• 1391001-96-9 tert-butyl ((4aS,5S,7aS)-5-(difluoromethyl)-7a-(2-fluoro-5-(5-methoxypyrazine-2-carboxamido)phenyl)-4a,5,7,7a-tetrahydro-4H-furo[3,4-d][1,3]thiazin-2-yl)carbamate 
• 1391001-78-7 N-(3-((4aS,5S,7aS)-2-amino-5-(difluoromethyl)-4a,5,7,7a-tetrahydro-4H-furo[3,4-d][1,3]thiazin-7a-yl)-4-fluorophenyl)-5-methoxypyrazine-2-carboxamide 
• 1398112-75-8 rac-5-methoxy-pyridine-2-carboxylic acid [3-(1-amino-3-difluoromethyl-3,4-dihydro-pyrrolo[1,2-a]pyrazin-3-yl)-4-fluoro-phenyl]-amide 
• 1398112-67-8 rac-5-methoxy-pyrazine-2-carboxylic acid [3-(1-amino-3-methyl-3,4-dihydro-pyrrolo[1,2-a]pyrazin-3-yl)-phenyl]-amide 
• 1398112-71-4 (R)-5-methoxy-pyrazine-2-carboxylic acid [3-(1-amino-7-fluoro-3-methyl-3,4-dihydro-pyrrolo[1,2-a]pyrazin-3-yl)-4-fluoro-phenyl]-amide 
• 1443035-49-1 N-{3-(3R)-(5-amino-2-(difluoromethylene)-3-methyl-3,6-dihydro-2H-1,4-oxazin-3-yl)-4-fluorophenyl}-5-methoxypyrazine-2-carboxamide 
• 1624605-50-0 N-(3-((4S,6S)-2-benzamido-4-(fluoromethyl)-6-(trifluoromethyl)-5,6-dihydro-4H-1,3-oxazin-4-yl)-4-fluorophenyl)-5-methoxypyrazine-2-carboxamide 

Relevant articles and documents

SELECTIVE OCTAHYDRO-CYCLOPENTA[C] PYRROLE NEGATIVE MODULATORS OF NR2B

Compounds that selectively negatively modulate NMDA receptors containing an NR1/NR2B subunit, pharmaceutical compositions comprising the compounds, and methods of treating a disease using the compounds are disclosed. Such diseases include, without limitation, neurological dysfunction such as Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, multiple sclerosis, and seizure disorders; emotional disorders; depression; bipolar disorder; obsessive-compulsive disorder; and other anxiety disorders.

SYNTHESIS OF BACE1 INHIBITORS

The present invention provides a one step carbonylation of a compound of formula II in the presence of water to afford a compound of formula (I), useful in processes to manufacture BACE inhibitors.

FUSED AMINODIHYDROTHIAZINE DERIVATIVES

The present invention relates to a fused aminodihydrothiazine derivative of formula (I): wherein X is hydrogen or fluorine; R is monofluoromethyl or difluoromethyl; and pharmaceutically acceptable salts thereof; which compound has an Aβ production inhibitory effect or a BACE1 inhibitory effect and is useful as a prophylactic or therapeutic agent for a neurodegenerative disease caused by Aβ and typified by Alzheimer-type dementia.

FUSED AMINODIHYDROTHIAZINE DERIVATIVES

The present invention relates to a fused aminodihydrothiazine derivative of formula (I): wherein X is hydrogen or fluorine;A is CH or N;Y is methyl, ethyl, monofluoromethyl, difluoromethyl, trifluoromethyl, difluoroethyl, methoxy, ethoxy, methoxymethyl or —C≡N; and pharmaceutically acceptable salts thereof; which compound has an Aβ production inhibitory effect or a BACE1 inhibitory effect and is useful as a prophylactic or therapeutic agent for a neurodegenerative disease caused by Aβ and typified by Alzheimer-type dementia.

FUSED AMINODIHYDROTHIAZINE DERIVATIVES USEFUL AS BACE INHIBITORS

The present invention relates to a fused aminodihydrothiazine derivative of formula (I): wherein X is hydrogen or fluorine; A is CH or N; Y is methyl, ethyl, monofluoromethyl, difluoromethyl, trifluoromethyl, difluoroethyl, methoxy, ethoxy, methoxymethyl or -C≡N; and pharmaceutically acceptable salts thereof; which compound has an Αβ production inhibitory effect or a BACEl inhibitory effect and is useful as a prophylactic or therapeutic agent for a neurodegenerative disease caused by Αβ and typified by Alzheimer-type dementia.

FUSED AMINODIHYDROTHIAZINE DERIVATIVES

The present invention relates to a fused aminodihydrothiazine derivative of formula (I): wherein X is hydrogen or fluorine; R is monofluoromethyl or difluoromethyl; and pharmaceutically acceptable salts thereof; which compound has an Αβ production inhibit

NEW COMPOUNDS 806

The present invention relates to new compounds of formula (I) and to pharmaceutical composition containing said compounds and to the use of said compounds in therapy. The present invention further relates to processes for the preparation of said compounds and to new intermediates useful in the preparation thereof.